{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:20:07Z","timestamp":1773296407505,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-5039-5","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T13:18:42Z","timestamp":1543497522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Anurag K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hennon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd L.","family":"Demmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Picone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth U.","family":"Dexter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chumy","family":"Nwogu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristopher","family":"Attwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Fung-Kee-Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish K.","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai","family":"Yendamuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge A.","family":"Gomez-Suescun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"issue":"9","key":"5039_CR1","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","volume":"17","author":"K Furuse","year":"1999","unstructured":"Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol. 1999;17(9):2692\u20139.","journal-title":"J Clin Oncol"},{"issue":"19","key":"5039_CR2","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/jnci\/djr325","volume":"103","author":"WJ Curran Jr","year":"2011","unstructured":"Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst. 2011;103(19):1452\u201360.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5039_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16(2):187\u201399.","journal-title":"Lancet Oncol"},{"issue":"5","key":"5039_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.jtcvs.2011.07.059","volume":"142","author":"KA Higgins","year":"2011","unstructured":"Higgins KA, Chino JP, Ready N, Onaitis MW, Berry MF, D'Amico TA, et al. Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer. J Thorac Cardiovasc Surg. 2011;142(5):1175\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"5039_CR5","first-page":"656","volume":"40","author":"E Meacci","year":"2011","unstructured":"Meacci E, Cesario A, Cusumano G, Lococo F, D'Angelillo R, Dall'armi V, et al. Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt. Eur J Cardiothorac Surg. 2011;40(3):656\u201363.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"5039_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2016.08.015","volume":"121","author":"J Nyman","year":"2016","unstructured":"Nyman J, Hallqvist A, Lund JA, Brustugun OT, Bergman B, Bergstrom P, et al. SPACE - a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother Oncol. 2016;121(1):1\u20138.","journal-title":"Radiother Oncol"},{"issue":"2","key":"5039_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.meddos.2011.06.009","volume":"37","author":"KL Martin","year":"2012","unstructured":"Martin KL, Gomez J, Nazareth DP, Warren GW, Singh AK. Quantification of incidental mediastinal and hilar irradiation delivered during definitive stereotactic body radiation therapy for peripheral non-small cell lung cancer. Med Dosim. 2012;37(2):182\u20135.","journal-title":"Med Dosim"},{"issue":"5","key":"5039_CR8","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.ijrobp.2008.07.070","volume":"73","author":"L Kepka","year":"2009","unstructured":"Kepka L, Maciejewski B, Withers RH. Does incidental irradiation with doses below 50 gy effectively reduce isolated nodal failures in non-small-cell lung cancer: dose-response relationship. Int J Radiat Oncol Biol Phys. 2009;73(5):1391\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2, Supplement","key":"5039_CR9","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1016\/j.ijrobp.2017.06.246","volume":"99","author":"S Rathod","year":"2017","unstructured":"Rathod S, Jeremic B, Fidarova E, Faheem M, Lau FN, Sharma V, Ammar C, Forbe A, Agarwal JP. Quality of Life Outcomes in a Phase 3 Randomized Trial of Optimization of Treatment of Advanced Non\u2013small Cell Lung Cancer Using Radiation Therapy and Chemotherapy: IAEA Multicentric Randomized Phase 3 Study (NCT00864331). Int J Radiat Oncol Biol Phys. 2017;99(2, Supplement):S103\u2013S4.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2, Supplement","key":"5039_CR10","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1016\/j.ijrobp.2017.06.247","volume":"99","author":"B Jeremic","year":"2017","unstructured":"Jeremic B, Ghosh S, Fidavora E, Faheem M, Agarwal JP, Lau FN, Sharma V, Ammar C, Azmy A, Forbe A, Brincat S. The International Atomic Energy Agency Randomized Trial on Chemotherapy With or Without Radiation Therapy in Advanced Non\u2013small Cell Lung Cancer (NCT00864331). Int J Radiat Oncol Biol Phys. 2017;99(2, Supplement):S103\u2013S4.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"5039_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/01.JTO.0000263726.89512.0c","volume":"2","author":"M Zielinski","year":"2007","unstructured":"Zielinski M. Transcervical extended mediastinal lymphadenectomy: results of staging in two hundred fifty-six patients with non-small cell lung cancer. J Thorac Oncol. 2007;2(4):370\u20132.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"5039_CR12","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.ijrobp.2012.11.011","volume":"85","author":"J Feddock","year":"2013","unstructured":"Feddock J, Arnold SM, Shelton BJ, Sinha P, Conrad G, Chen L, et al. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys. 2013;85(5):1325\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5039_CR13","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.ijrobp.2016.06.035","volume":"96","author":"A Bezjak","year":"2016","unstructured":"Bezjak A, Paulus R, Gaspar L, Timmerman R, Straube W, Ryan WF, et al. Efficacy and toxicity analysis of NRG oncology\/RTOG 0813 trial of stereotactic body radiation therapy (SBRT) for centrally located non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2016;96(2):S8.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5039_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s13193-013-0220-4","volume":"4","author":"M Huang","year":"2013","unstructured":"Huang M, Manuballa S, Demmy T, Yendamuri S. Transcervical extended mediastinal lymphadenectomy - indications and technique. Indian J Surg Oncol. 2013;4(2):138\u201341.","journal-title":"Indian J Surg Oncol"},{"issue":"3","key":"5039_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ejcts.2004.12.008","volume":"27","author":"J Kuzdzal","year":"2005","unstructured":"Kuzdzal J, Zielinski M, Papla B, Szlubowski A, Hauer L, Nabialek T, et al. Transcervical extended mediastinal lymphadenectomy--the new operative technique and early results in lung cancer staging. Eur J Cardiothorac Surg. 2005;27(3):384\u201390 discussion 90.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"5039_CR16","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.athoracsur.2017.05.022","volume":"104","author":"S Yendamuri","year":"2017","unstructured":"Yendamuri S, Battoo A, Dy G, Chen H, Gomez J, Singh AK, et al. Transcervical extended Mediastinal lymphadenectomy: experience from a north American Cancer center. Ann Thorac Surg. 2017;104(5):1644\u20139.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"5039_CR17","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/j.cllc.2017.10.010","volume":"19","author":"SJ Ma","year":"2018","unstructured":"Ma SJ, Serra LM, Syed YA, Hermann GM, Gomez-Suescun JA, Singh AK. Comparison of single- and three-fraction schedules of stereotactic body radiation therapy for peripheral early-stage non-small-cell lung Cancer. Clin Lung Cancer. 2018;19(2):e235\u2013e40.","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"5039_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ijrobp.2015.07.2260","volume":"93","author":"GM Videtic","year":"2015","unstructured":"Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, et al. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung Cancer: NRG oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys. 2015;93(4):757\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5039_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijrobp.2004.12.060","volume":"63","author":"O Chapet","year":"2005","unstructured":"Chapet O, Kong FM, Quint LE, Chang AC, Ten Haken RK, Eisbruch A, et al. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys. 2005;63(1):170\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5039_CR20","volume-title":"The EORTC QLQ-C30 scoring manual (3rd edition)","author":"PM Fayers","year":"2001","unstructured":"Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. The EORTC QLQ-C30 scoring manual (3rd edition). European Organisation for Research and Treatment of Cancer: Brussels; 2001."},{"issue":"5","key":"5039_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"5039_CR22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S0360-3016(03)00063-4","volume":"56","author":"NA Taylor","year":"2003","unstructured":"Taylor NA, Liao ZX, Stevens C, Walsh G, Roth J, Putnam J Jr, et al. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery. Int J Radiat Oncol Biol Phys. 2003;56(3):616\u201325.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"5039_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/sj.bjc.6603075","volume":"94","author":"DC Betticher","year":"2006","unstructured":"Betticher DC, Hsu Schmitz SF, Totsch M, Hansen E, Joss C, von Briel C, et al. Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study. Br J Cancer. 2006;94(8):1099\u2013106.","journal-title":"Br J Cancer"},{"issue":"3","key":"5039_CR24","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.athoracsur.2012.04.088","volume":"94","author":"A Amini","year":"2012","unstructured":"Amini A, Correa AM, Komaki R, Chang JY, Tsao AS, Roth JA, et al. The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy. Ann Thorac Surg. 2012;94(3):914\u201320.","journal-title":"Ann Thorac Surg"},{"issue":"9687","key":"5039_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","volume":"374","author":"KS Albain","year":"2009","unstructured":"Albain KS, Swann RS, Rusch VW, Turrisi AT 3rd, Shepherd FA, Smith C, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009;374(9687):379\u201386.","journal-title":"Lancet"},{"key":"5039_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1748-717X-4-5","volume":"4","author":"EP Sulman","year":"2009","unstructured":"Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiat Oncol. 2009;4:5.","journal-title":"Radiat Oncol"},{"issue":"1","key":"5039_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3857\/roj.2016.01928","volume":"35","author":"E Kim","year":"2017","unstructured":"Kim E, Song C, Kim MY, Kim JS. Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer. Radiat Oncol J. 2017;35(1):55\u201364.","journal-title":"Radiat Oncol J"},{"issue":"4","key":"5039_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.prro.2012.09.002","volume":"3","author":"S Garg","year":"2013","unstructured":"Garg S, Gielda BT, Turian JV, Liptay M, Warren WH, Bonomi P, et al. Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection. Pract Radiat Oncol. 2013;3(4):287\u201393.","journal-title":"Pract Radiat Oncol"},{"key":"5039_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.lungcan.2016.05.014","volume":"98","author":"MJ Boyer","year":"2016","unstructured":"Boyer MJ, Gu L, Wang X, Kelsey CR, Yoo DS, Onaitis MW, et al. Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer. Lung Cancer. 2016;98:76\u20138.","journal-title":"Lung Cancer"},{"key":"5039_CR30","doi-asserted-by":"crossref","unstructured":"PORT Meta-analyis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet. 1998;352(9124):257\u201363.","DOI":"10.1016\/S0140-6736(98)06341-7"},{"issue":"9","key":"5039_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","volume":"7","author":"JY Douillard","year":"2006","unstructured":"Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzales-Larriba JL, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (adjuvant Navelbine international Trialist association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006;7(9):719\u201327.","journal-title":"Lancet Oncol"},{"issue":"3","key":"5039_CR32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ijrobp.2008.01.044","volume":"72","author":"JY Douillard","year":"2008","unstructured":"Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA, et al. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine international Trialist association (ANITA) randomized trial. Int J Radiat Oncol Biol Phys. 2008;72(3):695\u2013701.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"5039_CR33","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1200\/JCO.2014.58.5380","volume":"33","author":"CG Robinson","year":"2015","unstructured":"Robinson CG, Patel AP, Bradley JD, DeWees T, Waqar SN, Morgensztern D, et al. Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base. J Clin Oncol. 2015;33(8):870\u20136.","journal-title":"J Clin Oncol"},{"issue":"3","key":"5039_CR34","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/JTO.0000000000000411","volume":"10","author":"JL Mikell","year":"2015","unstructured":"Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, et al. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base. J Thorac Oncol. 2015;10(3):462\u201371.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"5039_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/JTO.0000000000000406","volume":"10","author":"CD Corso","year":"2015","unstructured":"Corso CD, Rutter CE, Wilson LD, Kim AW, Decker RH, Husain ZA. Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database. J Thorac Oncol. 2015;10(1):148\u201355.","journal-title":"J Thorac Oncol"},{"issue":"38","key":"5039_CR36","doi-asserted-by":"crossref","first-page":"62998","DOI":"10.18632\/oncotarget.18071","volume":"8","author":"HH Wang","year":"2017","unstructured":"Wang HH, Deng L, Wen QL, Zhang CZ, Zaorsky NG, Zhang BL, et al. Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) stage IIIA-N2 non-small cell lung cancer. Oncotarget. 2017;8(38):62998\u20133013.","journal-title":"Oncotarget"},{"issue":"3","key":"5039_CR37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.ijrobp.2015.11.020","volume":"94","author":"HW Lee","year":"2016","unstructured":"Lee HW, Noh OK, Oh YT, Choi JH, Chun M, Kim HI, et al. Radiation therapy-first strategy after surgery with or without adjuvant chemotherapy in stage IIIA-N2 non-small cell lung Cancer. Int J Radiat Oncol Biol Phys. 2016;94(3):621\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"5039_CR38","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/cncr.27823","volume":"119","author":"CM Booth","year":"2013","unstructured":"Booth CM, Shepherd FA, Peng Y, Darling G, Li G, Kong W, et al. Time to adjuvant chemotherapy and survival in non-small cell lung cancer: a population-based study. Cancer. 2013;119(6):1243\u201350.","journal-title":"Cancer"},{"issue":"17","key":"5039_CR39","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1158\/1078-0432.CCR-16-2946","volume":"23","author":"AK Singh","year":"2017","unstructured":"Singh AK, Winslow TB, Kermany MH, Goritz V, Heit L, Miller A, et al. A pilot study of stereotactic body radiation therapy combined with Cytoreductive nephrectomy for metastatic renal cell carcinoma. Clin Cancer Res. 2017;23(17):5055\u201365.","journal-title":"Clin Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5039-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-5039-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5039-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T09:05:13Z","timestamp":1605517513000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-5039-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5039"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-5039-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,29]]},"assertion":[{"value":"18 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional review board approval was obtained at the Roswell Park Comprehensive Cancer Center (I 223812). ClinicalTrials.gov identifying number NCT01781741. All patients provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1183"}}